돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2047406생성일: 2026년 10월 27일

Cesium carbonate → 2-[3-(3-Fluoro-4-morpholin-4-yl-piperidin-1-yl)-phenyl]-1-methyl-1H-benzoimidazole

https://huagongshe.com/reaction/2047406

반응식

참여 물질

역할이름HCID투입량
반응물Cesium carbonateHCID 10796—
반응물Binap, (A+-)-HCID 634876—
반응물2-(3-bromophenyl)-1-methyl-1H-benzimidazoleHCID 962451—
반응물4-(3-Fluoro-piperidin-4-yl)-morpholineHCID 68670746—
촉매palladium(II) acetateHCID 167845—
용매TolueneHCID 1140—
생성물2-[3-(3-Fluoro-4-morpholin-4-yl-piperidin-1-yl)-phenyl]-1-methyl-1H-benzoimidazoleHCID 68671327—

반응 단계

4-(3-Fluoro-piperidin-4-yl)-morpholine (0.085 g, 0.45 mmol), 2-(3-Bromo-phenyl)-1-methyl-1H-benzoimidazole (described in method N, step a, b) (0.10 g, 0.35 mmol), and cesium carbonate (10.50 g, 32.2 mmol) were placed into a dry sealed 7 mL vial under nitrogen and dry toluene (0.4 mL) was added. At the same time Palladium acetate (0.016 g, 0.07 mmol), and BINAP (0.065 g, 0.10 mmol) were placed into another dry sealed 7 mL vial under nitrogen and diluted with dry toluene (0.8 mL) After about 20 minutes the resulting suspension was added to the vial containing the starting materials.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08592463B2
출처 데이터셋uspto-grants-2013_11
ORD IDord-639d0b6d540e4f4bafe23bf639e62468
출처 메모uspto-grants-2013_11